Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 6 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 11779635

    Subcutaneous administration of ADAMTS13

    Takeda Pharmaceutical Company Limited · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted
  2. US 11760803

    Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments

    Takeda Pharmaceutical Company Limited · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  3. US 11746155

    Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  4. US 11744892

    Constrained conditionally activated binding proteins

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  5. US 11749394

    Method and apparatus for providing a pharmacokinetic drug dosing regimen

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  6. US 11746109

    Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  7. US 11744893

    Constrained conditionally activated binding proteins

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  8. US 11739152

    Antibodies which bind Fc receptors (FcRn)

    Takeda Pharmaceutical Company Limited · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  9. US 11725024

    Antibody drug conjugates

    Takeda Pharmaceutical Company Limited · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  10. US 11713311

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  11. US 11707536

    Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

    Takeda Pharmaceutical Company Limited · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  12. US 11702419

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  13. US 11696893

    Preparation comprising vonoprazan

    Takeda Pharmaceutical Company Limited · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted
  14. US 11685780

    Single domain antigen binding domains that bind human Trop2

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  15. US 11684632

    Maribavir isomers, compositions, methods of making and methods of using

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  16. US 11672831

    Use of adipose tissue-derived stromal stem cells in treating fistula

    Takeda Pharmaceutical Company Limited · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  17. US 11666594

    Antibody-drug conjugates comprising a cyclic dinucleotide

    Takeda Pharmaceutical Company Limited · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  18. US 11670409

    Method and apparatus for providing a pharmacokinetic drug dosing regiment

    Takeda Pharmaceutical Company Limited · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  19. US 11661593

    Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

    Takeda Pharmaceutical Company Limited · Granted May 30, 2023 · Expires May 25, 2043

    granted
  20. US 11660318

    Use of adipose tissue-derived stromal stem cells in treating fistula

    Takeda Pharmaceutical Company Limited · Granted May 30, 2023 · Expires May 25, 2043

    granted
  21. US 11660328

    GLP-2 analogs and peptibodies for administration before, during or after surgery

    Takeda Pharmaceutical Company Limited · Granted May 30, 2023 · Expires May 25, 2043

    granted
  22. US 11655241

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 23, 2023 · Expires May 18, 2043

    granted
  23. US 11649206

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted May 16, 2023 · Expires May 11, 2043

    granted
  24. US 11613586

    Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies

    Takeda Pharmaceutical Company Limited · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted